Hearing on "Maintaining America’s Leadership in Biomedical Innovation: FDA’s Role in Advancing U.S. Drug Development"

The Subcommittee on Health of the Committee on Energy and Commerce will hold a hearing on Wednesday, July 15, 2026, at 10:15 a.m. (ET) in the John D. Dingell Room, 2123 Rayburn House Office Building.  The hearing is entitled “Maintaining America’s Leadership in Biomedical Innovation: FDA’s Role in Advancing U.S. Drug Development.”